Brenner Tumor - 10 Studies Found Status Study Completed Study Name: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condition: Brenner Tumor Fallopian Tube Cancer Drug: belinostat Given IV Completed Study Name: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condition: Brenner Tumor Fallopian Tube Cancer Biological: sargramostim Given Completed Study Name: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condition: Brenner Tumor Fallopian Tube Cancer Drug: carboplatin Given intrap Completed Study Name: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condition: Brenner Tumor Fallopian Tube Cancer Procedure: adjuvant therapy Drug: paclitax Completed Study Name: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condition: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Biological: Urokinase-Derived Peptide A6 Completed Study Name: MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer Condition: Malignant Ovarian Brenner Tumor Ovarian Clear Cell Adenocarcino Date: 2014-02-19 Interventions: Other: Laboratory Biomarker Analysis Withdrawn Study Name: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Condition: Fatigue Malignant Ovarian Mixed Epithelial Tumor Neuropath Date: 2011-12-14 Interventions: Dietary Supplement: Acetyl-L-Carnitine Hydrochloride Active, not recruiting Study Name: Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condition: Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Date: 2009-04-24 Interventions: Drug: Elesclomol Sodium Given Recruiting Study Name: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condition: Clear Cell Adenocarcinoma Fallopian Tube Clear Cell Adenocarcinoma Biological: Bevacizumab Given Completed Study Name: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Condition: Chemotherapeutic Agent Toxicity Endometrial Adenocarcinoma Date: 2008-12-20 Interventions: Drug: Paclitaxel Given IV or i
